Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Profile Treatment Approach Name | PIK3CA inhibitor |
Profile Name | NRAS G12S |
Drug Class | PIK3CA inhibitor 26 |
Therapy |
PubMed Id | Reference Title | Details |
---|---|---|
(19629070) | Targeting PI3K signalling in cancer: opportunities, challenges and limitations. | Full reference... |
(24608574) | Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials. | Full reference... |